Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)
Subject: Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)Solicitation Number: ARPA-H-SOL-26-163Notice Type: SOLICITNAICS: 541715Notice Published: 10-14-26Response Due: 10-21-26Agency: Department of Health and Human ServicesOffice: NATIONAL INSTITUTES OF HEALTHContact: SPECTRA Team This email address is being protected from spambots. You need JavaScript enabled to view it.Office Address: Washington, DC 20005Related Notices:
Click for official SAM (FBO) notice, additional information, and accompanying attachments
Amendment 1 (10/14/2026): Update due dates and/or times of all TAs SPECTRA will identify and act on autism trajectories, the evolving developmental paths individuals follow across the lifespan from the prenatal period through aging, spanning autism characteristics, co-occurring conditions, and functional outcomes together with the genetic, biological, behavioral, iatrogenic (medical influences), environmental factors and their nonlinear interactions. Rather than examining these factors in isolation, SPECTRA will examine how they combine and interact, including their nonlinear interactions, to produce autism and its co-occurring conditions over time. SPECTRA will also develop technologies that serve two purposes at once: extending reliable assessment beyond the clinic while improving everyday communication, function, and quality of life. The same tools people use to live more fully will also generate the data that drive measurement and personalized care.